UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A Proposal of a Cost-Effectiveness Modeling Approach for Heart Failure Treatment Assessment: Considering the Short- and Long-Term Impact of Hospitalization on Event Rates

PharmacoEconomics, 2022-11, Vol.40 (11), p.1095-1105

2022

Volltextzugriff (PDF)

The cost-utility of open prostatectomy compared with active surveillance in early localised prostate cancer

BMC health services research, 2014-04, Vol.14 (1), p.163-163, Article 163

2014

Volltextzugriff (PDF)

A Decision-Analytic Model to Assess the Cost-Effectiveness of Etelcalcetide vs. Cinacalcet

PharmacoEconomics, 2018-05, Vol.36 (5), p.603-612

2018

Volltextzugriff (PDF)

Patient-reported outcomes in CodeBreaK 200: Sotorasib versus docetaxel for previously treated advanced NSCLC with KRAS G12C mutation

Lung cancer (Amsterdam, Netherlands), 2024-10, Vol.196, p.107921, Article 107921

2024

Volltextzugriff (PDF)

Costs and effects of intra-operative fluorescence molecular imaging - A model-based, early assessment

PloS one, 2018-06, Vol.13 (6), p.e0198137-e0198137

2018

Volltextzugriff (PDF)

Cost-effectiveness of different strategies to prevent breast and ovarian cancer in German women with a BRCA 1 or 2 mutation

The European journal of health economics, 2018-04, Vol.19 (3), p.341-353

2018

Volltextzugriff (PDF)

The excess health care costs of KardioPro, an integrated care program for coronary heart disease prevention

Health policy (Amsterdam), 2015-06, Vol.119 (6), p.778-786

2015

Volltextzugriff (PDF)

Effects of a 3-year nurse-based case management in aged patients with acute myocardial infarction on rehospitalisation, mortality, risk factors, physical functioning and mental health. a secondary analysis of the randomized controlled KORINNA study

PloS one, 2015-03, Vol.10 (3), p.e0116693-e0116693

2015

Volltextzugriff (PDF)

Economic modeling of risk-adapted screen-and-treat strategies in women at high risk for breast or ovarian cancer

The European journal of health economics, 2019-07, Vol.20 (5), p.739-750

2019

Volltextzugriff (PDF)

Cost-effectiveness of romosozumab for the treatment of postmenopausal women at very high risk of fracture in Canada

Archives of osteoporosis, 2022-12, Vol.17 (1), p.71, Article 71

2022

Volltextzugriff (PDF)

Real-world cost-effectiveness of denosumab for the treatment of postmenopausal osteoporosis in Taiwan

Archives of osteoporosis, 2021-12, Vol.16 (1), p.155-155, Article 155

2021

Volltextzugriff (PDF)

Breast cancer attributable costs in Germany: a top-down approach based on sickness funds data

PloS one, 2012-12, Vol.7 (12), p.e51312-e51312

2012

Volltextzugriff (PDF)

Cost-of-illness studies based on massive data: a prevalence-based, top-down regression approach

The European journal of health economics, 2016-04, Vol.17 (3), p.235-244

2016

Volltextzugriff (PDF)

Transparency vs. closed-door policy: Do process characteristics have an impact on the outcomes of coverage decisions? A statistical analysis

Health policy (Amsterdam), 2013-10, Vol.112 (3), p.187-196

2013

Volltextzugriff (PDF)

The association between health system development and the burden of cardiovascular disease: an analysis of WHO country profiles

PloS one, 2013-04, Vol.8 (4), p.e61718-e61718

2013

Volltextzugriff (PDF)

Communicating the Parameter Uncertainty in the IQWiG Efficiency Frontier to Decision-Makers

Health economics, 2015-04, Vol.24 (4), p.481-490

2015

Volltextzugriff (PDF)

A multi-perspective cost-effectiveness analysis comparing rivaroxaban with enoxaparin sodium for thromboprophylaxis after total hip and knee replacement in the German healthcare setting

BMC health services research, 2012-07, Vol.12 (1), p.192-192, Article 192

2012

Volltextzugriff (PDF)

The effectiveness of the cardiovascular disease prevention programme 'KardioPro' initiated by a German sickness fund: a time-to-event analysis of routine data

PloS one, 2014-12, Vol.9 (12), p.e114720-e114720

2014

Volltextzugriff (PDF)

Cost-effectiveness of a multifactorial fracture prevention program for elderly people admitted to nursing homes

The European journal of health economics, 2015-06, Vol.16 (5), p.517-527

2015

Volltextzugriff (PDF)

Progression-free survival as a surrogate endpoint in advanced breast cancer

International journal of technology assessment in health care, 2008-10, Vol.24 (4), p.371-383

2008

Volltextzugriff (PDF)

Financial incentives in the German Statutory Health Insurance: New findings, new questions

Health policy (Amsterdam), 2010-06, Vol.96 (1), p.51-56

2010

Volltextzugriff (PDF)

Cost effectiveness of external hip protectors in the hospital setting: a modeling study

Nursing economic, 2014-03, Vol.32 (2), p.89

2014

Volltextzugriff (PDF)

Validity, reliability and responsiveness of the EQ-5D in German stroke patients undergoing rehabilitation

Quality of life research, 2012-09, Vol.21 (7), p.1205-1216

2012

Volltextzugriff (PDF)

Economic evaluation of genetic screening for Lynch syndrome in Germany

Genetics in medicine, 2015-10, Vol.17 (10), p.765-773

2015

Volltextzugriff (PDF)

1 – 25 von 55

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(55)
Mit Volltextzugriff
(52)

Publikationsform

Sprache

Englisch
(52)
Deutsch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRASG12C mutation: a randomised, open-label, phase 3 trial

A Proposal of a Cost-Effectiveness Modeling Approach for Heart Failure Treatment Assessment: Considering the Short- and Long-Term Impact of Hospitalization on Event Rates

The cost-utility of open prostatectomy compared with active surveillance in early localised prostate cancer

A Decision-Analytic Model to Assess the Cost-Effectiveness of Etelcalcetide vs. Cinacalcet

Patient-reported outcomes in CodeBreaK 200: Sotorasib versus docetaxel for previously treated advanced NSCLC with KRAS G12C mutation

Costs and effects of intra-operative fluorescence molecular imaging - A model-based, early assessment

Cost-effectiveness of different strategies to prevent breast and ovarian cancer in German women with a BRCA 1 or 2 mutation

The excess health care costs of KardioPro, an integrated care program for coronary heart disease prevention

Effects of a 3-year nurse-based case management in aged patients with acute myocardial infarction on rehospitalisation, mortality, risk factors, physical functioning and mental health. a secondary analysis of the randomized controlled KORINNA study

Economic modeling of risk-adapted screen-and-treat strategies in women at high risk for breast or ovarian cancer

Cost-effectiveness of romosozumab for the treatment of postmenopausal women at very high risk of fracture in Canada

Real-world cost-effectiveness of denosumab for the treatment of postmenopausal osteoporosis in Taiwan

Breast cancer attributable costs in Germany: a top-down approach based on sickness funds data

Cost-of-illness studies based on massive data: a prevalence-based, top-down regression approach

Transparency vs. closed-door policy: Do process characteristics have an impact on the outcomes of coverage decisions? A statistical analysis

The association between health system development and the burden of cardiovascular disease: an analysis of WHO country profiles

Communicating the Parameter Uncertainty in the IQWiG Efficiency Frontier to Decision-Makers

A multi-perspective cost-effectiveness analysis comparing rivaroxaban with enoxaparin sodium for thromboprophylaxis after total hip and knee replacement in the German healthcare setting

The effectiveness of the cardiovascular disease prevention programme 'KardioPro' initiated by a German sickness fund: a time-to-event analysis of routine data

Cost-effectiveness of a multifactorial fracture prevention program for elderly people admitted to nursing homes

Progression-free survival as a surrogate endpoint in advanced breast cancer

Financial incentives in the German Statutory Health Insurance: New findings, new questions

Cost effectiveness of external hip protectors in the hospital setting: a modeling study

Validity, reliability and responsiveness of the EQ-5D in German stroke patients undergoing rehabilitation

Economic evaluation of genetic screening for Lynch syndrome in Germany

Suchergebnisse filtern